Blucora Inc (INSP) Institutional Investor Sentiment Analysis

Sentiment for Blucora Inc (INSP)

Blucora Inc (INSP) institutional sentiment increased to 1.25 in 2018 Q2. Its up 0.20, from 1.05 in 2018Q1. The ratio has improved, as 94 active investment managers increased and opened new positions, while 75 sold and decreased stock positions in Blucora Inc. The active investment managers in our partner’s database now possess: 43.70 million shares, up from 43.55 million shares in 2018Q1. Also, the number of active investment managers holding Blucora Inc in their top 10 positions increased from 2 to 3 for an increase of 1. Sold All: 17 Reduced: 58 Increased: 59 New Position: 35.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea . The company has market cap of $917.44 million. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It currently has negative earnings.

The stock decreased 1.94% or $0.85 during the last trading session, reaching $42.87. About 125,415 shares traded. Inspire Medical Systems, Inc. (INSP) has 0.00% since December 6, 2017 and is . It has underperformed by 15.62% the S&P500.

Analysts await Inspire Medical Systems, Inc. (NYSE:INSP) to report earnings on February, 5. After $-0.22 actual earnings per share reported by Inspire Medical Systems, Inc. for the previous quarter, Wall Street now forecasts 45.45 % negative EPS growth.

Harvest Capital Strategies Llc holds 3.81% of its portfolio in Inspire Medical Systems, Inc. for 725,000 shares. Hillcrest Asset Management Llc owns 432,956 shares or 2.99% of their US portfolio. Moreover, Oberweis Asset Management Inc has 1.95% invested in the company for 209,614 shares. The Wisconsin-based Timpani Capital Management Llc has invested 0.83% in the stock. Park West Asset Management Llc, a California-based fund reported 550,000 shares.

Since January 1, 0001, it had 1 insider purchase, and 5 sales for $6.70 million activity.

Inspire Medical Systems, Inc. (NYSE:INSP) Ratings Coverage

Ratings analysis reveals 50% of Inspire Medical Systems’s analysts are positive. Out of 2 Wall Street analysts rating Inspire Medical Systems, 1 give it “Buy”, 1 “Sell” rating, while 0 recommend “Hold”. The lowest target is $3100 while the high is $57. The stock’s average target of $44 is 2.64% above today’s ($42.87) share price. INSP was included in 2 notes of analysts from October 29, 2018. The firm has “Sell” rating by Berenberg given on Wednesday, November 28.

More notable recent Inspire Medical Systems, Inc. (NYSE:INSP) news were published by: Fortune.com which released: “Term Sheet — Monday, April 23 – Fortune” on April 23, 2018, also Bizjournals.com with their article: “Biz Digest: Panera Bread headed downtown; new estate-size homes in the works – Orlando Business Journal” published on October 31, 2018, Globenewswire.com published: “Inspire Medical Systems, Inc. Reports First Quarter 2018 Financial Results – GlobeNewswire” on June 07, 2018. More interesting news about Inspire Medical Systems, Inc. (NYSE:INSP) were released by: Benzinga.com and their article: “Benzinga’s Daily Biotech Pulse: Biohaven Sells Right To Drug, Obseva To Sell Shares – Benzinga” published on June 19, 2018 as well as Warriortradingnews.com‘s news article titled: “Inspire Medical Systems | $INSP Stock | Sleep Apnea Treatment Firm Raises $108M After Going Public – Warrior Trading News” with publication date: May 04, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.